Search results for "Obstructive"

showing 10 items of 609 documents

Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: A systematic review

2015

Objectives/Hypothesis Mandibular advancement devices are an alternative to continuous positive airway pressure for patients with mild or moderate obstructive sleep apnea/hypopnea syndrome (OSAHS). The main aim of this review was to assess the effectiveness of different devices in treating OSAHS, based on polysomnographic measurements such as the apnea/hypopnea index (AHI) and oxygen saturation, and on changes in the upper airway and improvements in the most common symptoms: snoring and somnolence. Their adverse effects were also noted. Study Design Systematic review. Methods Following an exhaustive search in the Medline, Scopus, and Cochrane Library databases, 22 articles published in the p…

business.industrymedicine.medical_treatmentDentistryApneaExcessive daytime sleepiness030206 dentistryCochrane Librarymedicine.diseaserespiratory tract diseasesObstructive sleep apnea03 medical and health sciences0302 clinical medicinestomatognathic systemOtorhinolaryngologymedicineContinuous positive airway pressuremedicine.symptomAirwaybusinessHypopnea030217 neurology & neurosurgerySomnolenceThe Laryngoscope
researchProduct

Measurement of Pharyngeal Pressure in Patients using Nasal CPAP

1995

In patients with obstructive sleep apnea syndrome (OSAS), nasal continuous positive airway pressure (nCPAP) prevents pharyngeal collapse by applying positive pressure transnasally. Currently there are not objective criteria to determine whether surgical improvement of nasal resistance is necessary in patients undergoing nCPAP treatment. In 16 patients with documented OSAS, inspiratory and expiratory pressures in the pharynx were measured during nCPAP with pressures ranging from 5 to 20 mbar. Identical studies were performed in 12 patients with severe nasal obstruction without OSAS and in eight normal patients. The results of each group were compared to the nasal resistance as measured by a…

business.industrymedicine.medical_treatmentPharynxPositive pressurerespiratory systemmedicine.diseaseObstructive sleep apneaPharyngeal muscles03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureAcoustic rhinometryOtorhinolaryngology030220 oncology & carcinogenesisAnesthesiaotorhinolaryngologic diseasesMedicineIn patientContinuous positive airway pressure030223 otorhinolaryngologybusinessNoseAmerican Journal of Rhinology
researchProduct

Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea : data from t…

2020

Background and aim: Obstructive sleep apnea (OSA) is an independent risk factor for dyslipidemia. The current study examined the effects of positive airway pressure (PAP) treatment on lipid status in the European Sleep Apnea Database (ESADA). Methods: The prospective cohort study enrolled 1564 OSA subjects (74% male, mean age 54 ± 11y, body mass index (BMI) 32.7 ± 6.6 kg/m2 and apnea-hypopnea index (AHI) 40.3 ± 24.4 n/h) undergoing PAP therapy for at least three months (mean 377.6 ± 419.5 days). Baseline and follow-up total cholesterol (TC) from nine centers were analyzed. Repeated measures and logistic regression tests (adjusted for age, sex, weight changes, lipid lowering medication, PAP …

cardiovascular riskAdultMalemedicine.medical_specialtySettore MED/10 - Malattie Dell'Apparato RespiratorioPositive airway pressure03 medical and health sciences0302 clinical medicineInternal medicinePositive airway pressuremedicineCardiovascular risk Cholesterol Hypoxia Sleep apneaHumanspositive airway pressureProspective StudiesRisk factorProspective cohort studyHypoxiaAgedSleep Apnea ObstructiveFramingham Risk ScoreContinuous Positive Airway Pressurebusiness.industryhypoxiaSleep apneaSleep apneacholesterolGeneral MedicineMiddle Agedmedicine.diseasesleep apneaCardiovascular riskObstructive sleep apneaCardiovascular risk ; Cholesterol ; Hypoxia ; Positive airway pressure ; Sleep apnea.Cholesterol030228 respiratory systemPatient ComplianceFemaleHuman medicinebusinessBody mass index030217 neurology & neurosurgeryDyslipidemiaSleep medicine
researchProduct

Cluster Analysis of Home Polygraphic Recordings in Symptomatic Habitually-Snoring Children: A Precision Medicine Perspective

2022

(1) Background: Sleep-disordered breathing (SDB) is a frequent problem in children. Cluster analyses offer the possibility of identifying homogeneous groups within a large clinical database. The application of cluster analysis to anthropometric and polysomnographic measures in snoring children would enable the detection of distinctive clinically-relevant phenotypes; (2) Methods: We retrospectively collected the results of nocturnal home-based cardiorespiratory polygraphic recordings and anthropometric measurements in 326 habitually-snoring otherwise healthy children. K-medoids clustering was applied to standardized respiratory and anthropometric measures, followed by Silhouette-based statis…

children; cluster analysis; obstructive sleep apnea; polygraphy; sleep apnea; sleep-disordered breathing; snoringpolygraphychildrensleep-disordered breathingGeneral Medicinesleep apneaobstructive sleep apneasnoringcluster analysisJournal of Clinical Medicine
researchProduct

Biomarkers in obstructive respiratory diseases: An update

2012

Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation of the airways, with the involvement of many inflammatory cells and mediators. Traditionally, this inflammation is thought to spread to a systemic level, thus inducing damage of different organs. However, other pathogenetic mechanisms could take part to the above-described process, and some open questions need to be solved. Due to the burden and increasing prevalence of COPD, the opportunity to find biomarkers that can potentially be useful in identifying individuals with the disease, or better, prior to symptoms onset, to diagnose and properly manage the respiratory symptoms, as well as to evaluate the re…

chronic obstructiveSputumBiomarkerSettore MED/10 - Malattie Dell'Apparato RespiratorioOutcome assessmentPulmonary Disease Chronic ObstructiveC-Reactive ProteinForced Expiratory VolumeHumansUteroglobinPulmonary diseaseBiomarkersHumanBiomarkers; Pulmonary disease chronic obstructive; Outcome assessment
researchProduct

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome

2021

Background and Objectives: Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are usually associated with multi-morbidity. The aim of this study was to retrospectively investigate the prevalence of comorbidities in a cohort of patients with OSAS and COPD-OSAS overlap syndrome (OS) patients and to explore differences between these two groups. Materials and Methods: Included were consecutive OS patients and OSAS patients who had been referred to our sleep laboratory, and were matched in terms of sex, age, BMI, and smoking history. Presence of comorbidities was recorded based on their medical history and after clinical and laboratory examination. Results: …

comorbiditiemedicine.medical_specialtyMedicine (General)obstructive sleep apnea syndromeComorbiditySettore MED/10 - Malattie Dell'Apparato Respiratoriooverlap syndromecomorbiditiesArticlechronic obstructive pulmonary diseaseFEV1/FVC ratioPulmonary Disease Chronic ObstructiveR5-920cardiovascular diseaseInternal medicinemedicineHumansRetrospective StudiesCOPDSleep Apnea Obstructivebusiness.industryOverlap syndromeGeneral Medicinemedicine.diseaseComorbiditynervous system diseasesRespiratory Function Testsrespiratory tract diseasesObstructive sleep apneaApnea–hypopnea indexCohortbusinessDyslipidemiaMedicina
researchProduct

The difference in risk of chronic pulmonary disease morbidity and mortality between elite athletes and ordinary men in Finland

2020

Introduction: The impact of a history of competitive sports on later smoking behavior and occurrence of chronic pulmonary diseases is poorly known. We investigated how a history of elite level sports predicted later pulmonary disease morbidity and mortality. Methods: Chronic pulmonary disease incidence were assessed from national hospital and cause-of-death registers from 1970 to 2015 among Finnish male former elite athletes (n=2078) and matched controls (n=1453) alive in 1970 (mean age 45.0 years). Hazard ratios (HRs) were calculated by Cox proportional hazards model. In 1985, cohort members reported on their smoking habits, engagement in physical activity/sports and physician-diagnosed ch…

former athlete(s)physical activitycopdasthmasmokingemphysemaobstructive pulmonary diseasetupakointiastmacohort studychronic bronchitiskeuhkosairaudetkeuhkoahtaumatautikrooniset tauditchronic diseasefyysinen aktiivisuusurheilijat
researchProduct

Coexistence of frailty syndrome and the level of health behaviors in elderly patients with chronic obstructive pulmonary disease

2023

Wprowadzenie: Przyspieszenie tempa starzenia się populacji, związane z tym ryzyko występowania zespołu słabości oraz wzrost liczby osób żyjących z przewlekłą obturacyjną chorobą płuc (POChP) powodują, że przyszłe kierunki polityki zdrowotnej powinny się skupiać na działaniach z zakresu promocji zdrowia, potęgowaniu zachowań prozdrowotnych, utrzymaniu lub poprawie sprawności funkcjonalnej starzejących się ludzi. Cel pracy: Analiza współwystępowania zespołu kruchości oraz nasilenia zachowań zdrowotnych u pacjentów w wieku podeszłym z POChP, jak również ustalenie czynników determinujących nasilenie zachowań zdrowotnych. Materiał i metody: Zbadano 100 pacjentów z rozpoznaniem POChP (średnia wie…

health behaviorstarzenie sięagingfrailtyprzewlekła obturacyjna choroba płuczespół słabościzachowania zdrowotnechronic obstructive pulmonary diseaseStudia Medyczne
researchProduct

Nitric oxide metabolites (nitrite and nitrate) in several clinical condition.

2013

We determined the concentration of nitric oxide metabolites (NO2-+NO3-), expressed as NOx, in several clinical conditions. Regarding this, we have examined 25 subjects with arterial hypertension, 41 subjects with chronic kidney disease in conservative treatment, 106 subjects with metabolic syndrome subdivided according to the presence (n = 43) or not (n = 63) of diabetes mellitus, 48 subjects with obstructive sleep apnea syndrome (OSAS), 14 women with systemic sclerosis complicated with Raynaud's phenomenon, 42 dialyzed subjects and 105 young subjects with acute myocardial infarction (AMI). In subjects with arterial hypertension, chronic kidney disease, metabolic syndrome, systemic sclerosi…

inorganic chemicalsAdultMaledialysimedicine.medical_specialtysistemic sclerosiPhysiologykidney diseasemedicine.medical_treatmentNOxNitric OxideAMIRisk FactorsPhysiology (medical)Internal medicineDiabetes mellitusmedicineDiabetes MellitusHumansMyocardial infarctionRenal Insufficiency ChronicDialysisNitritesMetabolic SyndromeNitratesbusiness.industryOSASApneaHematologyrespiratory systemMiddle Agedmedicine.diseaseObstructive sleep apneaEndocrinologyNOx; hypertension; kidney disease; metabolic syndrome; OSAS; sistemic sclerosis; dialysis; AMICardiovascular DiseasesCase-Control StudiesHypertensionCardiologyFemalemedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessHypopneaKidney diseaseClinical hemorheology and microcirculation
researchProduct

Comorbidities and clinical outcomes of a lung cancer screening trial participants with chronic obstructive pulmonary disease in three-year follow-up

2022

To improve the effectiveness of lung cancer screening using low-dose computed tomography (LDCT), the presence of smoking-related comorbidities that may significantly affect mortality in this group should be taken into account. Material and methods: A questionnaire survey and spirometry tests were conducted in a group of 730 respondents as part of a lung cancer screening study between 2016 and 2018. People diagnosed with COPD underwent a three-year follow-up to assess the incidence of medical events. Results: Our study confirmed that cardiovascular diseases (CVDs) were the most common comorbidities in patients who were diagnosed with COPD and participated in LDCT lung cancer screening. Among…

lung cancerscreeningoncologydiagnostic radiologyGeneral Medicinerespiratory tractchronic obstructive pulmonary diseaseEuropean Journal of Translational and Clinical Medicine
researchProduct